• Skip to primary navigation
  • Skip to main content
  • Skip to footer
BOMSS

BOMSS

British Obesity & Metabolic Surgery Society

  • Home
  • About BOMSS
    • About BOMSS
      • Overview
      • Vision, mission and values
      • Equality, diversity and inclusion
    • Who we are
      • Trustees
      • Council
      • Patient Safety Committee
      • Endoscopy Committee
      • IHP Committee
      • NBSR
    • Membership
  • Healthcare Professionals
    • Clinical Resources
  • ASM 2023
    • Annual Scientific Meeting 2022
    • Annual Scientific Meeting 2021
  • Events
  • Contact
  • About
        • Overview
        • Who we are
          • Council
          • Trustees
          • Patient Safety Committee
          • Endoscopy Committee
          • IHP Committee
          • NBSR
        • Membership
        • Equality, diversity and inclusion
        • Vision, mission and values
        • Contact
  • Patient information
    • What is obesity?
    • How is obesity measured?
    • Obesity-linked health problems
    • Managing obesity
      • Your mindset
      • Medication
      • NHS Tiered Care Weight Management Pathway
      • Bariatric and Metabolic Surgery
        • Adjustable Gastric Banding
        • Gastric Bypass – Roux en Y Gastric Bypass
        • Sleeve Gastrectomy
        • One-anastomosis (Mini) Gastric Bypass (OAGB)
        • Bilio-Pancreatic Diversion With Duodenal Switch (BPD-DS)
        • Bariatric surgery for people with type 2 diabetes (T2D)
    • Accessing Tier 4 Services
  • ASM
    • ASM 2023
    • ASM 2022
    • ASM 2021
    • Event calendar
  • Healthcare professionals
    • Clinical Resources

Bariatric surgery for people with type 2 diabetes (T2D)

You are here: Home / Patient information / Managing obesity / Bariatric and Metabolic Surgery / Bariatric surgery for people with type 2 diabetes (T2D)

Blood sugar levels are usually markedly improved immediately following bariatric surgery before any weight loss occurs. This means that most people can reduce the number of medications or stop their medications.

The term diabetes remission is used to describe people whose blood indicator of T2D, HbA1c returns to the normal range without any medications for a year a more. Importantly, the long-term complications of T2D such as kidney disease, neuropathy and eye problems are reduced by around a third following bariatric surgery. The chances of going into remission depend on how long a person has had T2D for prior to surgery; the closer to diagnosis the greater the chances which is why NICE recommend an expedited referral for assessment for bariatric surgery for people with type 2 diabetes duration of 10 years or less. The likelihood of T2D remission also depends on the severity of a person’s diabetes (current HbA1c and current medications).

Even in the absence of remission, bariatric surgery will lead to improved glucose control and reduce the number of medications needed for people with T2D.

Surgical options:

  • Adjustable Gastric Banding
  • Gastric Bypass
  • Sleeve Gastrectomy
  • One-anastomosis Gastric Bypass
  • Bilio-Pancreatic Diversion With Duodenal Switch
  • Bariatric surgery for people with type 2 diabetes

Footer

Quick links

  • Home
  • About
  • ASM
  • Events
  • Contact
  • Privacy policy

Contact

British Obesity & Metabolic Surgery Society CIO (BOMSS)
C/O Executive Business Support
Davidson Road
City Wharf
Lichfield
WS14 9DZ

[email protected]

01543 442 195

Copyright © 2023 British Obesity & Metabolic Surgery Society CIO    I

I   Registered charity No: 1192184